Thailand Point-of-Care Testing (POCT) Market, By Products (Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Diseases Testing Products, Pregnancy and Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-of-Abuse Testing Products, Fecal Occult Testing Products, Rapid Coagulation Testing, and other POC Products), Application (Blood Glucose Cardiac Monitoring, Hematology, Coagulation, Whole Blood Analysis, Vital Sign Monitoring, Non-Invasive Spo2 Monitoring, Non-Invasive Pco2 Monitoring, Blood Transfusion, and Others), Platform (Lateral Flow Assays/Immunochromatography Tests, Dipsticks, Molecular Diagnostics, Immunoassays, and Microfluidics), Prescription Mode (Prescription Based Testing and OTC Testing), Testing Type (Immunoassays, Cell-Based Assays, Nucleic Acid Amplification Testing, Clinical Chemistry Assays, and Hematology), End-Users Segment (Hospitals, Clinics, Laboratories, Home Care, Ambulatory Surgical Centers, Others), Distribution Channel (Direct and Retail Pharmacies) - Industry Trends and Forecast to 2030.
Thailand Point-of-Care Testing (POCT) Market Analysis and Size
The point-of-care testing (POCT) is characterized as testing that can be done close to the patient where a medical decision can be made immediately, including the results and monitoring. Point-of-care testing (POCT) is also called with-patient testing. It allows physicians to accurately measure real-time, lab-quality diagnostic results within less than minutes compared to hours. Currently, various products are available that provide rapid and accurate results and help patients better outcomes, which is expected to provide various other opportunities in the point-of-care testing market. However, lack of alignments in the lab results and the high cost of point-of-care testing products are expected to restrain market growth in the forecast period. Presence of major market player is providing an opportunity whereas the lack of trained professionals are challenging the market growth.
Data Bridge Market Research analyses that the Thailand point-of-care testing (POCT) market which was USD 139.18 million in 2022, would reach up to USD 251.94 million by 2030, and is expected to undergo a CAGR of 7.70% during the forecast period. “Glucose Monitoring Products” dominates the product segment of the Thailand point-of-care testing (POCT) market due to higher prevalence of diabetes. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Thailand Point-of-Care Testing (POCT) Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Products (Glucose Monitoring Products, Cardiometabolic Testing Products, Infectious Diseases Testing Products, Pregnancy and Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-of-Abuse Testing Products, Fecal Occult Testing Products, Rapid Coagulation Testing, and other POC Products), Application (Blood Glucose Cardiac Monitoring, Hematology, Coagulation, Whole Blood Analysis, Vital Sign Monitoring, Non-Invasive Spo2 Monitoring, Non-Invasive Pco2 Monitoring, Blood Transfusion, and Others), Platform (Lateral Flow Assays/Immunochromatography Tests, Dipsticks, Molecular Diagnostics, Immunoassays, and Microfluidics), Prescription Mode (Prescription Based Testing and OTC Testing), Testing Type (Immunoassays, Cell-Based Assays, Nucleic Acid Amplification Testing, Clinical Chemistry Assays, and Hematology), End-Users Segment (Hospitals, Clinics, Laboratories, Home Care, Ambulatory Surgical Centers, Others), Distribution Channel (Direct and Retail Pharmacies)
|
|
Countries Covered
|
Thailand
|
|
Market Players Covered
|
Bio-Rad Laboratories, Inc. (U.S.), bioMérieux SA (France), Trinity Biotech (Ireland), BD (U.S.), EKF Diagnostics (U.K.), Abbott (U.S.), Quidel Corporation (U.S.), Sienco, Inc. (U.S.), Danaher (U.S.), Chembio Diagnostics Systems, Inc. (U.S.), Nova Biomedical (U.S.), PTS Diagnostics (U.S.), AccuBioTech Co., Ltd (China), Beckman Coulter, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Sekisui Diagnostics (Japan), Instrumentation Laboratory (A Subsidiary Of Werfen) (U.S.), Xiamen Biotime Biotechnology Co., Ltd. (China), FUJIFILM Thailand Ltd. (Thailand)
|
|
Market Opportunities
|
|
Market Definition
Point of care testing (POCT) refers to medical diagnostic testing performed near or at the patient's location, often outside a traditional laboratory setting. It provides rapid results, typically within minutes, enabling immediate clinical decisions. POCT devices are portable and user-friendly, allowing healthcare professionals to perform tests at the bedside, in clinics, or even at home. Common applications include blood glucose monitoring, infectious disease testing, and pregnancy testing.
Thailand Point-of-Care Testing (POCT) Market Dynamics
Drivers
- Rising Demand for Convenience of Diagnostics
Patients and healthcare providers seek convenient testing options, and POCT devices are often portable, user-friendly, and require minimal sample preparation.
- Rising Demand for Chronic Disease Management
The rising prevalence of chronic diseases, such as diabetes and cardiovascular conditions, drives demand for regular monitoring, which POCT facilitates
Opportunities
- Increased Access to Healthcare
As POCT devices become more widely available and affordable, they can help increase access to healthcare services, especially in rural and underserved areas of Thailand. This can lead to improved healthcare outcomes and reduced healthcare disparities
- Early Disease Detection
POCT devices allow for rapid and convenient testing for various diseases and conditions, including infectious diseases, diabetes, and cardiovascular conditions. The early detection and diagnosis of these conditions can lead to more effective treatment and management, potentially reducing healthcare costs in the long run
Restraints/Challenges
- Regulatory Compliance
Meeting stringent regulatory requirements for POCT devices can be complex and time-consuming, leading to delays in product approvals and market entry
- High Cost
The initial cost of acquiring and implementing POCT devices, and ongoing operational expenses, can be a barrier for healthcare facilities, particularly in resource-limited settings
This point-of-care testing (POCT) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the point-of-care testing (POCT) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth
Recent Developments
- In 2020, Beckman Coulter, Inc. had introduced a total laboratory automation solution that sets a new standard for turnaround time. This automation solution services will help in getting good quality results and will improve laboratory operations. This will help the company in setting a new standard of quality services and will thus, help in generating more revenue in the future
- In 2017, Sekisui Diagnostics announced to the distribution of the Mesa Biotech Point of molecular care system for Flu A/Flu B. It helps physicians with rapid infectious disease diagnosis at the point of care with increased sensitivity. Thus, this will help the company in more revenue generation
Thailand Point-of-Care Testing (POCT) Market Scope
Thailand point-of-care testing (POCT) market is segmented on the basis of products, application, platform, prescription mode, testing type, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Products
- Glucose Monitoring Products
- Cardiometabolic Testing Products
- Infectious Diseases Testing Products
- Pregnancy and Fertility Testing Products
- Tumor/Cancer Marker Testing Products
- Urinalysis Testing Products
- Cholesterol Testing Products
- Hematology Testing Products
- Drug-of-Abuse Testing Products
- Fecal Occult Testing Products
- Rapid Coagulation Testing
- other POC Products
Application
- Blood Glucose Cardiac Monitoring
- Hematology
- Coagulation
- Whole Blood Analysis
- Vital Sign Monitoring
- Non-Invasive Spo2 Monitoring
- Non-Invasive Pco2 Monitoring
- Blood Transfusion
- Others
Platform
- Lateral Flow Assays/Immunochromatography Tests
- Dipsticks
- Molecular Diagnostics
- Immunoassays
- Microfluidics
Prescription Mode
- Prescription Based Testing
- OTC Testing
Testing Type
- Immunoassays
- Cell-Based Assays
- Nucleic Acid Amplification Testing
- Clinical Chemistry Assays
- Hematology
End-Users
- Hospitals
- Clinics
- Laboratories
- Home Care
- Ambulatory Surgical Centers
- Others
Distribution Channel
- Direct
- Retail Pharmacies
Competitive Landscape and Thailand Point-of-Care Testing (POCT) Market Share Analysis
The Thailand point-of-care testing (POCT) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Thailand presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company’s focus related to Thailand point-of-care testing (POCT) market.
Some of the major players operating in the Thailand point-of-care testing (POCT) market are:
- Bio-Rad Laboratories, Inc. (U.S.)
- bioMérieux SA (France)
- Trinity Biotech (Ireland)
- BD (Becton, Dickinson and Company) (U.S.)
- EKF Diagnostics (U.K.)
- Abbott (U.S.)
- Quidel Corporation (U.S.)
- Sienco, Inc. (U.S.)
- Danaher (U.S.)
- Chembio Diagnostics Systems, Inc. (U.S.)
- Nova Biomedical (U.S.)
- PTS Diagnostics (U.S.)
- AccuBioTech Co., Ltd (China)
- Beckman Coulter, Inc. (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Sekisui Diagnostics (Japan)
- Instrumentation Laboratory (A Subsidiary Of Werfen) (U.S.)
- Xiamen Biotime Biotechnology Co., Ltd. (China)
- FUJIFILM Thailand Ltd. (Thailand)
SKU-